EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exposure to androgen deprivation therapy and risk of anastomotic leakage after colorectal cancer surgery

Martin Rutegård, Isac Norrgård, John Moshtaghi-Svensson, Jaana Hagström, Ida Hed Myrberg, Anna Lantz, Suvi Rasilainen, Caroline Nordenvall, Malin Sund

Colorectal Disease · 2025-06 · 27 (6)

DOI: 10.1111/codi.70126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Colorectal Disease, online erschienen am 03.06.2025. Verfasst von Martin Rutegård und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Anastomotic Leak, Colorectal Neoplasms, Androgen Antagonists. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancerföreningen i Stockholm, Svenska Läkaresällskapet, Region Västerbotten.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The risk of anastomotic leakage after colorectal cancer surgery is higher in men, regardless of the anatomical location. Previous studies suggest that this might be due to hormonal differences. The aim of this work was to investigate whether androgen deprivation therapy influenced the incidence of anastomotic leakage.

Method

This is a nationwide registry‐based study of men operated on between 2007 and 2021 for colorectal cancer with an anastomosis. Exposure to androgen deprivation therapy (prescribed drugs or surgical castration) was related to anastomotic leakage using mixed‐effects logistic regression models. Two control groups were formed: one without and one with prostate cancer but without androgen deprivation. To study the potential target for androgen effect in intestinal tissue, androgen receptor expression was evaluated using immunohistochemistry in a smaller independent cohort to compare receptor expression in relation to leakage.

Results

Some 24 611 men were included in the registry study, of whom 2.4% were exposed to androgen deprivation therapy. In this exposed group, compared with unexposed men with and without prostate cancer, respectively, leak rates were 3.7%, 5.6% and 5.8%, respectively. After adjustment, a nonsignificant reduction of anastomotic leakage in the exposed group was detected (OR 0.70, 95% CI 0.45–1.09) compared with men without prostate cancer. Tissue expression of androgen receptor was very low among patients with and without leakage, albeit with a trend of higher expression among the latter.

Conclusion

Anastomotic leakage rates might be lower in men exposed to androgen deprivation therapy before surgery for colorectal cancer, although this finding must be interpreted cautiously. Effects on anastomotic healing do not seem to be mediated through classical androgen receptor signalling in the intestine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anastomotic LeakColorectal NeoplasmsAndrogen AntagonistsHumansMaleAgedMiddle AgedRegistriesReceptors, AndrogenRisk FactorsProstatic NeoplasmsIncidenceAnastomosis, SurgicalLogistic Models

Stichwörter der Autor:innen

anastomosishormonesleakmenoperationreceptor

Substanzen

Androgen AntagonistsReceptors, Androgen

Autor:innen und Institutionen

  • Department of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden.
  • Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Department of Oral Pathology and Radiology, University of Turku and Turku University Hospital, Turku, Finland.
  • Department of Pathology, Helsinki University and Helsinki University Hospital, Helsinki, Finland.
  • Translational Cancer Research Program Unit, University of Helsinki, Helsinki, Finland.

Förderung

  • Cancerföreningen i Stockholm
  • Svenska Läkaresällskapet
  • Region Västerbotten
  • Swedish Cancer and Allergy Foundation
  • Finska Läkaresällskapet
  • Umeå Universitet
  • Medicinska Understödsföreningen Liv och Hälsa

Zitieren

APA

Rutegård, M., Norrgård, I., Moshtaghi-Svensson, J., Hagström, J., Myrberg, I. H., Lantz, A., Rasilainen, S., Nordenvall, C., & Sund, M. (2025). Exposure to androgen deprivation therapy and risk of anastomotic leakage after colorectal cancer surgery. Colorectal Disease, 27(6). https://doi.org/10.1111/codi.70126

Vancouver

Rutegård M, Norrgård I, Moshtaghi-Svensson J, Hagström J, Myrberg IH, Lantz A, et al. Exposure to androgen deprivation therapy and risk of anastomotic leakage after colorectal cancer surgery. Colorectal Disease. 2025;27(6). doi:10.1111/codi.70126

BibTeX
@article{Rutegrd2025,
  author = {Rutegård, Martin and Norrgård, Isac and Moshtaghi-Svensson, John and Hagström, Jaana and Myrberg, Ida Hed and Lantz, Anna and Rasilainen, Suvi and Nordenvall, Caroline and Sund, Malin},
  title = {Exposure to androgen deprivation therapy and risk of anastomotic leakage after colorectal cancer surgery},
  journal = {Colorectal Disease},
  year = {2025},
  volume = {27},
  number = {6},
  doi = {10.1111/codi.70126}
}
Kostenlos starten →